ANTI-IDIOTYPIC ANTIBODY NEUTRALIZING THE INHIBITOR ACTIVITY OF A FACTOR VIII INHIBITOR ANTIBODY

摘要

The present invention is related to a monoclonal anti-idiotypic antibody directed against a Factor VIII inhibitor antibody binding to the domain A2 of Factor VIII, and to a cell line producing this monoclonal anti-idiotypic antibody, to the use of this monoclonal anti-idiotypic antibody as drug, and more particularly, to its use for the manufacturing of a drug to be used for the treatment of haemophilia A.